Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
GlobeNewswire
MIAMI, FL, May 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on..
MIAMI, FL, May 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on..
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Japan CL2020 Market Size, Forecast, and Emerging Insight - 2032" report has been..
LA JOLLA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global..